Roche CEO Expects Pharma Portfolio to Deliver Sales Growth Through 2030

2 weeks ago 9
The drugmaker’s on-market pharma portfolio, unneurotic with drugs for lupus, bosom crab and aggregate sclerosis, should offset generic contention until 2030, Chief Executive Thomas Schinecker said.
Read Entire Article